Skip to main content

ScienceDex / Researcher record

Glessner, Mary

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #21
  • Top 1% Funded
  • Sustained Excellence
  • Long-Funded

NIH Funding · FY2022

$58M
Full award amounts, FY2022
4
Records listing this PI
#21
By linked amount among FY2022 PIs
2012
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2012$2,166,6291#2,509
2013$2,231,9591#2,237
2014$2,220,0001#2,465
2015$2,279,0001#2,293
2016$2,445,1721#1,988
2017$2,512,2962#1,833
2018$2,849,7142#1,539
2019$2,859,8932#1,723
2021$3,005,7982#1,709
2022$57,962,4804#21
2023$7,318,4022#415

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20121 record
  2. FY20131 record
  3. FY20141 record
  4. FY20151 record
  5. FY20161 record
  6. FY20172 records
  7. FY20182 records
  8. FY20192 records
  9. FY20212 records
  10. FY2022 · selected4 records
  11. FY20232 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Glessner, Mary. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2022 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2012 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award records by amount

NIH award records listing Glessner, Mary as a PI. Multi-PI records show the full award amount for context.

  • 75N93021D00035-0-759302200001-1N01Contact PI
    Clinical Trial Management Support Services for ACTIV-2
    $48.6M
    award amount
  • 75N93022C00014-0-9999-1N01Contact PI
    NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)
    $7.1M
    award amount
  • 272201200004C-P00039-9999-1N01Contact PI
    DAIT CLINICAL SITE MONITORING CENTER
    $2.2M
    award amount
  • 271201800025I-P00006-27100001-1N02Contact PI
    POP: 09/28/2019-09/27/2020 CLINICAL SITE AND STUDY MONITORING FOR RESEARCH PARTNERSHIPS FOR GLOBAL MENTAL HEALTH.
    $49.1K
    award amount

Award organization

Organizations that administered FY2022 awards listing Glessner, Mary as a PI.

FY2022 award administered by Ppd Development LP (NC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2012
    First NIH Award
    Ppd Development LP
  2. 2012
    $500K Cumulative Funding
  3. 2012
    $1M Cumulative Funding
  4. 2012
    $2M Cumulative Funding
  5. 2012
    Entered Top 50% Nationally
    Ranked #2509
  6. 2012
    Entered Top 25% Nationally
    Ranked #2509
  7. 2014
    $5M Cumulative Funding
  8. 2016
    $10M Cumulative Funding
  9. 2016
    Entered Top 10% Nationally
    Ranked #1988
  10. 2022
    $25M Cumulative Funding
  11. 2022
    $50M Cumulative Funding
  12. 2022
    Entered Top 5% Nationally
    Ranked #21
  13. 2022
    Entered Top 1% Nationally
    Ranked #21